Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Core Study	STARTED	Placebo PBO/BMT	326
Core Study	STARTED	Bremelanotide BMT/BMT	327
Core Study	Received Intervention	Placebo PBO/BMT	319
Core Study	Received Intervention	Bremelanotide BMT/BMT	324
Core Study	COMPLETED	Placebo PBO/BMT	274
Core Study	COMPLETED	Bremelanotide BMT/BMT	190
Core Study	NOT COMPLETED	Placebo PBO/BMT	52
Core Study	NOT COMPLETED	Bremelanotide BMT/BMT	137
Open Label Extension	STARTED	Placebo PBO/BMT	239
Open Label Extension	STARTED	Bremelanotide BMT/BMT	124
Open Label Extension	COMPLETED	Placebo PBO/BMT	95
Open Label Extension	COMPLETED	Bremelanotide BMT/BMT	49
Open Label Extension	NOT COMPLETED	Placebo PBO/BMT	144
Open Label Extension	NOT COMPLETED	Bremelanotide BMT/BMT	75

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02333071/flow